Programs

Global Alliance to Eliminate Lymphatic Filariasis (GAELF)

The Global Alliance to Eliminate Lymphatic Filariasis (GAELF) was created to eliminate one of the world's leading causes of disability and disfigurement as a public health problem by the year 2020. An estimated 120 million people in at least 80 countries of the world suffer from the disease, and one billion (20% of the world's population) are at risk of infection.

Global Campaign to End Fistula

The Global Campaign to End Fistula seeks to reduce the prevalence of fistula in developing countries.

Global Fund for Women

The Global Fund for Women provides support for community based groups that examine maternal health care.

Global Pharma Health Fund

The Global Pharma Health Fund e.V. (GPHF) is a charitable organization initiated and funded exclusively by donations from Merck KGaA, Darmstadt Germany. In 2007, it took over the work of the former German Pharma Health Fund, which was set up in 1985. The organization aims to improve health care in the context of development assistance, in particular the use of the GPHF-Minilab in the fight against counterfeit drugs.

Global Polio Eradication Initiative

The Global Polio Eradication Initiative is a plan to eliminate childhood polio through extensive vaccination.

Guinea Worm Eradication Program (GWEP)

The Guinea Worm Eradication Program aims to rid future generations of guinea worm by the year 2005. Today, through the joint efforts of this initiative's many partners, the numbers of this disease have been reduced worldwide by 99 percent: from an estimated 3.5 million cases in 1986 to fewer than 35,000 reported cases in 2003. Today, it is the last one percent of the disease that is being fought.

Health at Home/Kenya

Health at Home/Kenya is an initiative coordinated by Global Business Coalition on HIV/AIDS, Tuberculosis & Malaria (GBC) that is providing home-based HIV/AIDS testing, TB screening and malaria bed nets, and de-worming for children into the homes of millions of Kenyans in a remote region with difficult access to health care. This innovative door-to-door model includes community preparation by local volunteers. To date, 97% of households in communities reached by the Health at Home/Kenya Impact Initiative have welcomed HIV counselors inside their homes.

Health Training at Egypt's National Training Institute

Pfizer works with the Egyptian Ministry of Health and Project HOPE to equip Egypt's National Training Institute (NTI) to provide state-of-the-art training for physicians, nurses and health professionals in Egypt and the Middle East in Infection Control, Family Medicine, Ophthalmology, Urology, General Surgery, Research Methodology, and Healthcare Management. Pfizer also helped upgrade laboratories and training equipment. Nearly 15,000 physicians have been trained through 220 training courses and 21 symposia.

Healthy Communities, Healthy Ecosystems

Community-based conservation and livelihood initiatives in vulnerable ecosystems.

HIV South Africa

HIV South Africa provides a wide variety of Johnson & Johnson healthcare products to community-based organizations that provide care and support to HIV patients in their homes.

HIVACAT public-private partnership for HIV vaccine development

The development of an effective vaccine is the only affordable and sustainable way to halt the HIV pandemic. In response to this challenge, the "HIVACAT" program was launched in 1995to design, develop and test potential HIV vaccine candidates in clinical trials for further development and regulatory approval. HIVACAT is a joint effort by two leading European HIV research institutions - the Hospital Clinic de Barcelona and Irsicaixa - and brings together the expertise and projects of more than 60 investigators from both centers.

Home-Based Newborn Care (HBNC) Initiative

The Home-Based Newborn Care (HBNC) initiative aims to train a sufficient number of community midwives in the most underserved areas to save newborns' lives. After taking a series of intensive courses, the community midwives can provide a continuum of quality care from pregnancy through birth and early infancy. The care includes drying the newborn, keeping the baby warm, initiating breastfeeding, giving special care to low-birth weight newborns, and diagnosing and treating common infant infections.

HPV Vaccine & Cervical Cancer

Cervical cancer is the second most common cancer in women worldwide, with about 500,000 new cases and 250,000 deaths occurring each year. Almost 80% of cases occur in low-income countries, where cervical cancer is the number one cause of cancer in women. Virtually all cervical cancer cases (99%) are linked to genital infection with human papillomavirus (HPV), a family of virus types which also causes genital warts and other forms of cancer.

Humana: Total Control of the Epidemic

'Only people can liberate themselves from the AIDS epidemic'. These are the motivating words behind the Total Control of the Epidemic (TCE) program, which was created by the International Humana People to People Movement. Driven by a grassroots door-to-door approach, TCE has been completed in 24 areas with 2,340,000 inhabitants and at present is operating in 62 areas with 6,170,000 inhabitants in Africa, 2 areas with 200,000 inhabitants in India and 3 areas with 300,000 inhabitants in China.

Hypertension Program in China

In 2006, Pfizer initiated a pilot Disease Management Program (DMaP-pilot) with the Shanghai Center for Disease Prevention and Control (CDC) to help manage and reverse hypertension and related cardiovascular risk factors, Cardiovascular disease is the leading cause of death and disease burden in urban centers in China, and the program is aligned with the Chinese government's aims to develop the national health care system at the community level and to cope with the heavy burden of chronic diseases.

IDF BRIDGES Program

Eli Lilly and Company has agreed to support the International Diabetes Federation's program 'Bringing Research In Diabetes to Global Environments and Systems' (BRIDGES) with USD 10 million funding over seven years. The BRIDGES grant research program will provide the opportunity to 'translate' lessons learned from clinical research to those who can benefit most: people with diabetes.

IMIFAP: HIV/AIDS Education

"I Want to, I Can prevent HIV/AIDS, is the slogan behind the Instituto Mexicano de Investigacion de Familia y Poblacion (IMIFAP) HIV prevention programs, which mobilize citizens to raise neighborhood HIV/AIDS awareness in Mexico. Johnson & Johnson supports an educational program for youth that utilizes the existing national network of middle schools to teach students about HIV prevention before they become sexually active, increasing the likelihood that these adolescents will practice safe sex in the future.

India Diabetes Educator Project

In November 2007, Bayer HealthCare, Becton Dickinson (BD), and Lilly agreed to support Project Hope's "India Diabetes Educator Project." This four-year, multi-million dollar collaborative program aims to help health care workers in India reduce morbidity and mortality related to diabetes and to combat the rapidly growing threat of diabetes there.

Infectious Disease Research Institute (IDRI)

The Infectious Disease Research Institute aims to develop vaccines to treat diseases of the poor.

Initiative Access: Access to Primary Health Care in Mali

Since 2001, the Novartis Foundation for Sustainable Development partners with the Ministries of Health and Social Development to improve the access to primary health care services in rural areas of Mali. Poor rural populations in Mali are faced with multiple obstacles when seeking healthcare such as mobilizing resources within their family and community to be able to overcome the great distance to the nearest health center.

Integrated Midwives Association of the Philippines

Johnson & Johnson supports training of IMAP midwives. More than 170 have been trained in the past few years.

International AIDS Vaccine Initiative (IAVI)

The International AIDS Vaccine Initiative (IAVI) was created in 1996 out of the recognition that the best long-term solution to the growing AIDS epidemic is a vaccine.

International Partnership for Microbicides (IPM)

The International Partnership for Microbicides provides the license and technology to develop, manufacture and distribute newly developed microbicide compounds to reduce sexual transmission of HIV in developing countries.

International Rescue Committee

The International Rescue Committee (IRC) reintegrates displaced children into society.

International Trachoma Initiative (ITI)

The International Trachoma Initiative (ITI) is the only organization dedicated solely to the elimination of blinding trachoma.

Pages